Dr Qian Zhang – Autoantibodies against type I IFNs in patients with life-threatening COVID-19 pneumonia

Event type: 
Event date: 
Tuesday, 28 September 2021 - 1:00pm to 2:00pm

Webinar via Zoom
Please click on the link just before the start of the webinar

Contact for inquiries: 
Rata Joseph, +61 (2) 9385 0900 or info@kirby.unsw.edu.au
Booking deadline: 


Kirby Institute Seminar Series presents

Dr Qian Zhang  

Dr Qian Zhang
Research Associate, Rockefeller University, USA

Qian Zhang is a pediatrician who leads the influenza/COVID pneumonia team in the Casanova lab at Rockefeller University, USA.

Twitter: Qian Zhang @tutu_ZQ, Casanova Lab @casanova_lab
COVID Human Genetic Effort website: www.covidhge.com



Auto-Abs neutralising type I IFNs predate SARS-CoV-2 infection and sharply increase in prevalence after the age of 70 years. They account for about 20% of both critical COVID-19 cases in the over-80s, and total fatal COVID-19 cases.

Opinions expressed in the Kirby Institute Seminar Series are solely those of the speaker and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.